Despite their significant contribution to the understanding of disease-associated mechanisms, mutant SOD1 models showed their limitations when effective therapeutic strategies failed to translate into a benefit for ALS patients. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.